Edward Hurwitz
Director of Finance/CFO bij TURMERIC ACQUISITION CORP.
Vermogen: 486 849 $ op 31-03-2024
Profiel
Edward M.
Hurwitz founded Precision BioVentures LLC in 2013, where he is working as Managing Director from 2013 and Viewpoint Therapeutics, Inc. in 2014, where he is working as Chairman.
Mr. Hurwitz also currently works at Rekindle Therapeutics, Inc., as Chairman, Biointervene, Inc., as Chairman, Alta BioPharma Management III LLC, as Director, MPM BioImpact, Inc, as Managing Director from 2017, MacroGenics, Inc., as Independent Director from 2004, ReCode Therapeutics, Inc., as Director, Dyne Therapeutics, Inc., as Independent Director from 2018, Protego Biopharma, Inc., as Director, Alta Embarcadero Biopharma Partners III LLC, as Manager, and Turmeric Acquisition Corp., as Chief Financial Officer.
Mr. Hurwitz also formerly worked at Alta Partners Management Co. LP, as Director, FoldRx Pharmaceuticals LLC, as Director, Sunesis Pharmaceuticals, Inc., as Independent Director from 2011 to 2013, Taligen Therapeutics, Inc., as Director, CARA Therapeutics, Inc., as Independent Director from 2006 to 2014, Avid Radiopharmaceuticals, Inc., as Director, Alta Partners VIII LP, as Director from 2002 to 2014, Calistoga Pharmaceuticals, Inc., as Director, Beacon Therapeutics (USA), Inc., as Independent Director from 2012 to 2022, Alta Partners LP, as Director from 2002 to 2014, Alta Biopharma Iii LP, as Director from 2002 to 2014, and Affymetrix, Inc., as Chief Financial Officer & Senior Vice President from 1997 to 2002.
Mr. Hurwitz received his undergraduate degree in 1985 from Cornell University, Masters Business Admin degree in 1990 from Haas School of Business, and graduate degree from Berkeley Law University of California.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
MACROGENICS, INC.
0.05% | 30-08-2023 | 33 074 ( 0.05% ) | 486 849 $ | 31-03-2024 |
DYNE THERAPEUTICS INC
-.--% | 24-05-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Edward Hurwitz
Bedrijven | Functie | Begin |
---|---|---|
MACROGENICS, INC. | Director/Board Member | 01-10-2004 |
DYNE THERAPEUTICS, INC. | Director/Board Member | 01-11-2018 |
TURMERIC ACQUISITION CORP. | Director of Finance/CFO | - |
Alta Embarcadero Biopharma Partners III LLC | Corporate Officer/Principal | - |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Director/Board Member | - |
Rekindle Therapeutics, Inc.
Rekindle Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rekindle Therapeutics, Inc. operates as an biotechnology company. The company is headquartered in Cambridge, MA. | Chairman | - |
Biointervene, Inc.
Biointervene, Inc. Pharmaceuticals: MajorHealth Technology Biointervene, Inc. operates as a biopharmaceutical company. The company was founded by Gary J. Bennett and Daniela Salvemini in 2014 and is headquartered in San Diego, CA. | Chairman | - |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01-01-2017 |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | Founder | 01-07-2014 |
░░░░░░░░░ ░░░░░░░░░░░ ░░░ | ░░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░ ░░░░░░░░░░ ░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Eerdere bekende functies van Edward Hurwitz
Bedrijven | Functie | Einde |
---|---|---|
░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░ ░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░ ░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Opleiding van Edward Hurwitz
Cornell University | Undergraduate Degree |
Haas School of Business | Masters Business Admin |
Berkeley Law University of California | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
CARA THERAPEUTICS, INC. | Health Technology |
MACROGENICS, INC. | Health Technology |
DYNE THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 21 |
---|---|
Affymetrix, Inc.
Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Alta Partners Management Co. LP
Alta Partners Management Co. LP Investment ManagersFinance Alta Partners Management Co. LP (Alta Partners) is a venture capital firm founded in 1996 by Jean Deleage, Guy Paul Nohra, Marino Polestra and Garrett P. Gruener. The firm is headquartered in Jackson, Wyoming. | Finance |
Alta BioPharma Management III LLC | |
FoldRx Pharmaceuticals LLC
FoldRx Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology FoldRx Pharmaceuticals, Inc. provides drug discovery and clinical development services. It develops and discovers products focusing on first-in-class, disease-modifying, small molecule therapeutics to treat diseases of protein misfolding. The company was founded by Jeffery W. Kelly and Susan L. Lindquist in 2003 and is headquartered in Cambridge, MA. | Health Technology |
Sunesis Pharmaceuticals, Inc.
Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. The firm's activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Alta Embarcadero Biopharma Partners III LLC | Finance |
Taligen Therapeutics, Inc.
Taligen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Taligen Therapeutics is a biotechnology company pioneering a new approach to treating inflammatory and immune diseases by regulating the complement system, a potent and ubiquitous immune pathway. Based on new insights and unique proprietary technology related to complement biology, Taligen is building a deep product candidate pipeline of novel protein therapeutics which selectively identify, target and concentrate on inflammatory tissues. Taligen's targeted drugs have been shown to naturally and broadly control aberrant inflammation in a broad array of genetic, orphan and large market diseases. Founded in 2004, Taligen Therapeutics maintains its headquarters in Cambridge, Massachusetts. | Health Technology |
Avid Radiopharmaceuticals, Inc.
Avid Radiopharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Avid Radiopharmaceuticals, Inc. provides molecular imaging services. It develops new molecular imaging agents capable of changing the medical management of significant, chronic human diseases by identifying the first stages of pathological change, potentially assisting in earlier diagnosis, and better management and development of new therapies. The company was founded by Daniel M. Skovronsky in 2004 and is headquartered in Philadelphia, PA. | Health Services |
Alta Partners VIII LP
Alta Partners VIII LP Investment ManagersFinance Alta Partners VIII LP seeks investment opportunities in both private and public companies located in the United States. The fund targets companies operating in the fields of biopharmaceuticals, medical technology and information technology. It provides financing for seed, early and later stage capital requirements. It acts as the lead investor and takes a seat on board of directors. | Finance |
Calistoga Pharmaceuticals, Inc.
Calistoga Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Calistoga Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The company was founded by Michael W. Gallatin, Roger Ulrich and Neil Giese in March 2006 and is headquartered in Tumwater, WA. | Health Technology |
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Beacon Therapeutics (USA), Inc.
Beacon Therapeutics (USA), Inc. Pharmaceuticals: GenericHealth Technology Applied Genetic Technologies Corp. is a clinical stage biotechnology company, which engages in the usage of a gene therapy platform to develop transformational genetic therapies for patients suffering from rare and debilitating diseases. The firm also focuses on conducting clinical trials in the field of ophthalmology, optogenetics, adrenoleukodystrophy, and otology. The company was founded by Richard Jude Samulski, Nicholas Muzyczka, William W. Hauswirth, Terence R. Flotte, and Barry J. Byrne on January 19, 1999 and is headquartered in Alachua, FL. | Health Technology |
Precision BioVentures LLC | |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. BiotechnologyHealth Technology Viewpoint Therapeutics, Inc. operates as a biotechnology company. It prevents and treats cataracts and presbyopia, and protein misfolding. The company was founded by Leah Makley in July of 2014 and is headquartered in San Francisco, CA. | Health Technology |
Alta Partners LP
Alta Partners LP Investment ManagersFinance Alta Partners LP is a venture capital private equity firm. The private company is based in San Francisco, CA. | Finance |
ReCode Therapeutics, Inc.
ReCode Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology ReCode Therapeutics, Inc. operates as a biopharmaceutical company. It develops precision medicines for pulmonary diseases. The company is headquartered in Irvin, TX. | Health Technology |
Alta Biopharma Iii LP
Alta Biopharma Iii LP Financial ConglomeratesFinance Alta Biopharma III LP provides investment services. The private company is based in San Francisco. | Finance |
Rekindle Therapeutics, Inc.
Rekindle Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Rekindle Therapeutics, Inc. operates as an biotechnology company. The company is headquartered in Cambridge, MA. | Commercial Services |
Biointervene, Inc.
Biointervene, Inc. Pharmaceuticals: MajorHealth Technology Biointervene, Inc. operates as a biopharmaceutical company. The company was founded by Gary J. Bennett and Daniela Salvemini in 2014 and is headquartered in San Diego, CA. | Health Technology |
Protego Biopharma, Inc.
Protego Biopharma, Inc. Miscellaneous Commercial ServicesCommercial Services Protego Biopharma operates as a biotechnology firm. The company is headquartered in San Diego, CA. | Commercial Services |
Turmeric Acquisition Corp.
Turmeric Acquisition Corp. Financial ConglomeratesFinance Turmeric Acquisition Corp. operates as a blank check company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 28, 2020 and is headquartered in Cambridge, MA. | Finance |